In late January 2026, India’s eastern state of West Bengal reported two confirmed cases of Nipah virus (NiV) infection, prompting swift international attention despite the outbreak’s limited scale. The cases, detected in healthcare workers at a private hospital in Barasat near Kolkata, mark the third documented Nipah outbreak in West Bengal and the latest in a series of sporadic events across India. While authorities have declared the situation contained—with no additional cases identified and all 196 traced contacts testing negative—the incident has sparked precautionary measures and heightened concern worldwide.
Nipah virus, a zoonotic pathogen first identified in Malaysia in 1998, is transmitted primarily from fruit bats (Pteropus species, commonly known as flying foxes), the natural reservoir. Spillover to humans can occur directly through contact with bat saliva, urine, or feces contaminating food—such as raw date palm sap in South Asia—or indirectly via intermediate hosts like pigs (as seen in the original Malaysian outbreak). Once in humans, the virus can spread person-to-person through close contact, respiratory droplets, or bodily fluids, particularly in healthcare or household settings.
The two recent cases in West Bengal involved a female and a male nurse, both around 25 years old, who developed symptoms in late December 2025. Infections were confirmed via RT-PCR testing on January 13, 2026. One patient experienced severe neurological complications but has shown improvement, while the other required mechanical ventilation as of late January. The epidemiological link between the cases points to transmission within the hospital environment, with no evidence of broader community spread.
India has faced multiple Nipah outbreaks over the years. West Bengal previously reported events in Siliguri (2001, with 66 cases and 45 deaths) and Nadia district (2007, five fatal cases). More recently, the southern state of Kerala has emerged as a hotspot, with significant outbreaks in 2018 (19 cases, 17 deaths), 2019, 2021, 2023, and as recently as July 2025 (four cases, two deaths). These recurrent incidents highlight ongoing risks in regions where fruit bats thrive and human activities intersect with bat habitats, often seasonally between December and May.
What makes Nipah particularly alarming is its high case fatality rate, ranging from 40% to 75% depending on the outbreak—far exceeding many other known viruses. There are no approved vaccines or specific antiviral treatments available; management relies solely on supportive care, including intensive care for severe respiratory and neurological symptoms like encephalitis.
The World Health Organization (WHO) classifies Nipah as a priority pathogen due to its epidemic potential, zoonotic origins, demonstrated human-to-human transmission, and the absence of countermeasures. It is handled at biosafety level 4, the highest containment level, similar to Ebola. Experts remain vigilant about the possibility of viral mutations enhancing transmissibility, though no such changes have been observed in the current cluster.
Despite the small number of cases, the outbreak has prompted enhanced airport screenings in several Asian countries, including Thailand, Malaysia, Singapore, Hong Kong, Vietnam, and others—particularly with increased travel expected around the Lunar New Year. These measures include health checks for arrivals from affected areas in India. The WHO assesses the global risk as low, with no recommendation for travel or trade restrictions, and emphasizes that the event poses moderate risk at the sub-national level but low risk nationally, regionally, and internationally.
Indian health authorities, drawing on experience from previous outbreaks, have implemented rapid contact tracing, isolation, surveillance, and public health responses to contain the cluster effectively. No sustained community transmission has been detected, and the outbreak appears limited to the hospital setting.
The global unease stems not from the current limited scope but from Nipah’s inherent dangers: its lethality, lack of preventive tools, potential for person-to-person spread, and history of recurring spillovers in a densely populated region. While the situation remains under control, it serves as a reminder of the persistent threat from emerging zoonotic viruses and the need for continued vigilance, surveillance, and investment in countermeasures.
About The Author
